Laura G. Eichorn is CFO at Imago BioSciences, Inc. (IMGO). They have made 6 open-market trades across 1 company since 2022, most recently 2023-01-11.
CIK 0001861067
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IMGO | 244,684 | $8.8M |
Shares reported on the most recent Form 4, priced at the 2023-01-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMGO | SELL | 2022-12-27 | 2022-12-29 | $35.93 | $111K | N/A | N/A | N/A |
| IMGO | SELL | 2022-12-15 | 2022-12-19 | $35.79 | $9.1M | +0.4% | N/A | N/A |
| IMGO | SELL · 10b5-1 | 2022-11-02 | 2022-11-04 | $18.00 | $10K | +8.6% | +120.9% | N/A |
| IMGO | SELL · 10b5-1 | 2022-08-22 | 2022-08-24 | $18.00 | $8K | -11.7% | -12.4% | +111.2% |
| IMGO | SELL · 10b5-1 | 2022-08-16 | 2022-08-18 | $19.50 | $18K | -22.2% | -19.6% | -5.0% |
| IMGO | SELL · 10b5-1 | 2022-07-20 | 2022-07-21 | $18.00 | $18K | -21.3% | -11.2% | -18.9% |
| IMGO | SELL | 2022-02-22 | 2022-02-24 | $21.60 | $173K | -4.4% | -11.4% | -37.0% |
| IMGO | SELL | 2022-02-11 | 2022-02-15 | $23.61 | $94K | -1.8% | -16.8% | -36.9% |
| IMGO | SELL | 2022-02-09 | 2022-02-11 | $21.56 | $86K | -5.4% | -17.3% | -43.8% |
| IMGO | SELL | 2022-01-12 | 2022-01-14 | $19.96 | $160K | -3.5% | +26.3% | +2.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.